Axe Compute Inc. (AGPU) shares rose nearly 590% over the last six months. This growth follows a strategic shift from cancer research to providing AI computing power. The company rebranded from Predictive Oncology in December 2025.
Axe Compute now focuses on renting graphics processing units (GPUs) required to train AI models. Leadership reports the company has secured $3 billion in business during this expansion.
The transition finalized after the sale of its cancer diagnostics subsidiary, Helomics, to DataMEDS AI on September 15, 2026. Axe Compute now operates as a pure-play neocloud GPU-as-a-Service provider.